Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada

被引:17
|
作者
Le, M. [1 ]
Ghazawi, F. M. [2 ]
Alakel, A. [3 ]
Netchiporouk, E. [1 ]
Rahme, E. [4 ]
Zubarev, A. [1 ]
Powell, M. [1 ]
Moreau, L. [1 ]
Roshdy, O. [1 ]
Glassman, S. J. [2 ]
Sasseville, D. [1 ]
Popradi, G. [5 ]
Litvinov, I., V [1 ,2 ]
机构
[1] McGill Univ, Div Dermatol, Montreal, PQ, Canada
[2] Univ Ottawa, Div Dermatol, Ottawa, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] McGill Univ, Div Clin Epidemiol, Montreal, PQ, Canada
[5] McGill Univ, Div Hematol, Montreal, PQ, Canada
关键词
Follicular lymphoma; incidence; mortality; geographic clustering; epidemiology; pollutants; herbicides; mining; clustering; NON-HODGKINS-LYMPHOMAS; CELL LYMPHOMA; RITUXIMAB MAINTENANCE; UNITED-STATES; LEUKEMIAS; RISK;
D O I
10.3747/co.26.4625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Follicular lymphoma (FL) is the most common indolent lymphoma and the 2nd most common non-Hodgkin lymphoma, accounting for 10%-20% of all lymphomas in the Western world. Epidemiologic and geographic trends of FL in Canada have not been investigated. Our study's objective was to analyze incidence and mortality rates and the geographic distribution of FL patients in Canada for 1992-2010. Methods Demographic and geographic patient data for FL cases were obtained using the Canadian Cancer Registry, the Registre quebecois du cancer, and the Canadian Vital Statistics database. Incidence and mortality rates and 95% confidence intervals were calculated per year and per geographic area. Rates were plotted using linear regression models to assess trends over time. Overall data were mapped using Microsoft Excel mapping software (Redmond, WA, U.S.A.) to identify case clusters across Canada. Results Approximately 22,625 patients were diagnosed with FL during 1992-2010. The age-standardized incidence rate of this malignancy in Canada was 38.3 cases per million individuals per year. Geographic analysis demonstrated that a number of Maritime provinces and Manitoba had the highest incidence rates, and that the provinces of Nova Scotia and Quebec had the highest mortality rates in the nation. Regional data demonstrated clustering of FL within cities or regions with high herbicide use, primary mining, and a strong manufacturing presence. Conclusions Our study provides a comprehensive overview of the FL burden and its geographic distribution in Canada. Regional clustering of this disease in concentrated industrial zones strongly suggests that multiple environmental factors might play a crucial role in the development of this lymphoma.
引用
收藏
页码:E473 / E481
页数:9
相关论文
共 50 条
  • [1] Long-term incidence, mortality and geographic trends of follicular lymphoma in Canada
    Le, M.
    Al Ghazawi, F. M.
    Alakel, A.
    Rahme, E.
    Powell, M.
    Moreau, L.
    Roshdy, O.
    Popradi, G.
    Sasseville, D.
    Litvinov, I.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (09) : B4 - B4
  • [2] Long-term incidence and geographic trends of follicular lymphoma in Canada: A population-based study
    Le, Michelle
    Ghazawi, Feras
    Popradi, Gizelle
    Glassman, Steven
    Sasseville, Denis
    Litvinov, Ivan
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB181 - AB181
  • [3] Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada
    François Lagacé
    Feras M. Ghazawi
    Michelle Le
    Elham Rahme
    Evgeny Savin
    Andrei Zubarev
    Akram Alakel
    Denis Sasseville
    Linda Moreau
    Sarkis Meterissian
    Ivan V. Litvinov
    [J]. Breast Cancer Research and Treatment, 2019, 178 : 683 - 691
  • [4] Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada
    Lagace, Francois
    Ghazawi, Feras M.
    Le, Michelle
    Rahme, Elham
    Savin, Evgeny
    Zubarev, Andrei
    Alakel, Akram
    Sasseville, Denis
    Moreau, Linda
    Meterissian, Sarkis
    Litvinov, Ivan V.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 683 - 691
  • [5] Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy
    Ghazawi, Feras M.
    Netchiporouk, Elena
    Rahme, Elham
    Tsang, Matthew
    Moreau, Linda
    Glassman, Steven
    Provost, Nathalie
    Gilbert, Martin
    Jean, Sara-Elizabeth
    Pehr, Kevin
    Sasseville, Denis
    Litvinov, Ivan V.
    [J]. CANCER, 2017, 123 (18) : 3550 - 3567
  • [6] A comprehensive analysis of seasonality patterns of incidence and mortality in Hodgkin lymphoma across geographic regions
    Borchmann, S.
    Mueller, H.
    Engert, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 74 - 74
  • [7] Epidemiology of Non-Hodgkin Lymphoma: Global Patterns of Incidence, Mortality, and Trends
    Sedeta, Ephrem
    Ilerhunmwuwa, Nosakhare
    Wasifuddin, Mustafa
    Uche, Ifeanyi
    Hakobyan, Narek
    Perry, Jamal
    Aiwuyo, Henry
    Abowali, Hesham
    Avezbakiyev, Boris
    [J]. BLOOD, 2022, 140 : 5234 - 5235
  • [8] Penile Invasive Squamous Cell Carcinoma: Analysis of Incidence, Mortality Trends, and Geographic Distribution in Canada
    Lagace, Francois
    Ghazawi, Feras M.
    Le, Michelle
    Savin, Evgeny
    Zubarev, Andrei
    Powell, Mathieu
    Moreau, Linda
    Sasseville, Denis
    Popa, Ioana
    Litvinov, Ivan, V
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2020, 24 (02) : 124 - 128
  • [9] Trends in excess mortality in follicular lymphoma at a population level
    Mounier, Morgane
    Bossard, Nadine
    Belot, Aurelien
    Remontet, Laurent
    Iwaz, Jean
    Dandoit, Mylene
    Girard-Boulanger, Stephanie
    Herry, Aurelie
    Woronoff, Anne-Sophie
    Casasnovas, Rene-Olivier
    Maynadie, Marc
    Giorgi, Roch
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (02) : 120 - 129
  • [10] Geographic patterns of gynecologic cancer incidence and mortality.
    Stewart, SL
    Thompson, TD
    German, RR
    Cardinez, CJ
    Friedman, C
    Wingo, PA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 477S - 477S